Your Health, We Care
Sunitinib is indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
Sunitinib is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).
Sunitinib is indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
Sunitinib is indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
from FDA，2021.08
Lucius Version of Sunitinib: Dosage and Administration, Indications, PrecautionsIndicationsSunitinib···【more】
Recommended：142025-01-12
Lucius Version of Sunitinib: Dosage and Administration, Indications, PrecautionsIndicationsSunitinib is a kinase inhibitor indicated for the treatment of:Gastrointestinal stromal t···【more】
Article source：Lucius LaosRelease date：2025-12-01Recommended：14
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
